PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v5i6.2763ArticleResearch Progress on the Effect of Sphingosine Kinase 2 on Gliomahttps://artdesignp.com/journal/PAR/5/6/10.26689/par.v5i6.2763WangChunpeng,LiuXiaohui,GuoShiwen2021562021-11-30Objective: The purpose of this study is to explore the role of sphingosine kinase 2 (SphK2) in the treatment of glioma, which is the most common primary tumor in the central nervous system. Methods: A total of 82 patients were included in this study, with 27 cases in the control group and 55 cases in the glioma group; the expressions of SphK2 and gp130 in the two groups were compared by immunohistochemical method, and the correlation between the two factors was analyzed. Results: Both SphK2 and gp130 were upregulated in the glioma group, and the two factors were significantly correlated. Conclusion: The high expression of SphK2 may play an important role in the occurrence, development, and diagnosis of glioma.

Eyüpoglu I, Buchfelder M, Savaskan N, 2013, Surgical Resection of Malignant Gliomas-Role in Optimizing Patient Outcome. Nature Reviews Neurology, 9: 141-151.

Cuddapah VA, Robel S, Watkins S, et al., 2014, A Neurocentric Perspective on Glioma Invasion. Nature Reviews Neuroscience, 15(7): 455-465.

Bellail AC, Hunter SB, Brat DJ, et al., 2004, Microregional Extracellular Matrix Heterogeneity in Brain Modulates Glioma Cell Invasion. International Journal of Biochemistry & Cell Biology, 36(6): 1046-1069.

Onishi M, Ichikawa T, Kurozumi K, et al., 2011, Angiogenesis and Invasion in Glioma. Brain Tumor Pathology, 28(1): 13-24.

Sanna MG, 2004, Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate. Journal of Biological Chemistry, 279(14): 13839-13848.

Maceyka M, Sankala H, Hait NC, et al., 2005, SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism. Journal of Biological Chemistry, 280(44): 37118-37129.

Shida D, Takabe K, Kapitonov D, et al., 2008, Targeting SphK1 as a New Strategy Against Cancer. Current Drug Targets, 9(8): 662-673.

Kajimoto T, Okada T, Miya S, et al., 2013, Ongoing Activation of Sphingosine 1-Phosphate Receptors Mediates Maturation of Exosomal Multivesicular Endosomes. Nature Communications, 4: 2712.

Figueroa J, Phillips LM, Shahar T, et al., 2017, Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Research, 77(21): 5808-5819.